We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$118M
AUM Growth
+$1.99M
Cap. Flow
+$889K
Cap. Flow %
0.76%
Top 10 Hldgs %
23.3%
Holding
183
New
19
Increased
63
Reduced
50
Closed
24

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.06M
2
STX icon
Seagate
STX
+$770K
3
GEN icon
Gen Digital
GEN
+$759K
4
EAT icon
Brinker International
EAT
+$751K
5
AMGN icon
Amgen
AMGN
+$661K

Sector Composition

Rank Sector Weight
1 Industrials 18.44%
2 Healthcare 17.12%
3 Consumer Staples 15.75%
4 Financials 14.88%
5 Consumer Discretionary 12.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AB icon
26
AllianceBernstein
AB
$3.36B
$1.28M 1.09%
54,778
+1,800
+3% +$36.5K
K
27
DELISTED
Kellanova
K
$1.25M 1.07%
17,447
-106
-0.6% -$7.32K
EMR icon
28
Emerson Electric
EMR
$82B
$1.21M 1.03%
22,270
+250
+1% +$12.1K
MMM icon
29
3M
MMM
$84.9B
$1.18M 1.01%
8,501
-819
-9% -$105K
INDB icon
30
Independent Bank
INDB
$3.96B
$1.13M 0.96%
24,578
+7,624
+45% +$340K
PB icon
31
Prosperity Bancshares
PB
$8.53B
$1.09M 0.93%
23,475
-3,300
-12% -$139K
PRXL
32
DELISTED
Parexel International Corp
PRXL
$1.08M 0.92%
17,186
+10,161
+145% +$626K
CSX icon
33
CSX Corp
CSX
$90.1B
$1.06M 0.91%
124,089
+2,100
+2% +$17K
ABBV icon
34
AbbVie
ABBV
$465B
$1.06M 0.9%
18,608
+1,950
+12% +$109K
BMY icon
35
Bristol-Myers Squibb
BMY
$130B
$1.06M 0.9%
16,550
+600
+4% +$37.8K
T icon
36
AT&T
T
$183B
$1.04M 0.89%
35,200
+596
+2% +$16.5K
MS icon
37
Morgan Stanley
MS
$324B
$981K 0.83%
39,214
+11,200
+40% +$286K
CVS icon
38
CVS Health
CVS
$121B
$974K 0.83%
9,385
-625
-6% -$60.8K
ZTS icon
39
Zoetis
ZTS
$30.3B
$942K 0.8%
21,245
+425
+2% +$18K
URI icon
40
United Rentals
URI
$61.6B
$933K 0.79%
15,000
-2,200
-13% -$122K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.11T
$918K 0.78%
6,473
+1,350
+26% +$179K
IBM icon
42
IBM
IBM
$234B
$852K 0.72%
5,884
-209
-3% -$26.7K
WMT icon
43
Walmart Inc
WMT
$858B
$852K 0.72%
37,311
+438
+1% +$9.6K
AAL icon
44
American Airlines Group
AAL
$8.45B
$840K 0.71%
20,475
-450
-2% -$18.1K
AKAM icon
45
Akamai
AKAM
$15.1B
$839K 0.71%
15,105
-100
-0.7% -$5.08K
MLM icon
46
Martin Marietta Materials
MLM
$36B
$829K 0.7%
5,200
-850
-14% -$117K
PNR icon
47
Pentair
PNR
$9.03B
$825K 0.7%
22,633
-521
-2% -$16.8K
CP icon
48
Canadian Pacific Kansas City
CP
$78.3B
$818K 0.7%
30,810
-2,705
-8% -$65.9K
UNP icon
49
Union Pacific
UNP
$169B
$810K 0.69%
10,188
+243
+2% +$18.8K
AWI icon
50
Armstrong World Industries
AWI
$6.77B
$798K 0.68%
16,500

Similar funds

New England Research & Management's Q1 2016 Portfolio in Review

As of Q1 2016, New England Research & Management held 183 positions worth $118M, up 1.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q1 2016 filing shows 19 new, 63 increased, 50 reduced and 24 closed positions. Its largest new stake was Valero Energy: 10,500 shares worth $673K. The largest sale was Medtronic, an estimated $1.06M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q1 2016 buy was Valero Energy: 10,500 shares worth $673K.
  • New England Research & Management added most to Kimberly-Clark in Q1 2016, an estimated $1.05M increase.
  • New England Research & Management's biggest Q1 2016 reduction was Amgen, cutting an estimated $661K.
  • New England Research & Management fully exited Medtronic in Q1 2016, selling an estimated $1.06M.
  • New England Research & Management's ten largest holdings make up 23% of its $118M portfolio in Q1 2016.
  • New England Research & Management opened 19 new positions and closed 24 in Q1 2016.
  • New England Research & Management's portfolio value rose 1.7% quarter-over-quarter to $118M.

Based on New England Research & Management's 13F filing for Q1 2016, filed 6 Apr 2016.